Nexus AG

Earnings Release • May 27, 2004

News Details

Ad-hoc | 27 May 2004 08:20

NEXUS: Sales and profit improved over last year’s levels…

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– NEXUS: Sales and profit improved over last year’s levels; international business increased Villingen-Schwenningen, May 27, 2004: Nexus AG, the medical software specialist, was able to increase its sales revenue in the first quarter of 2004 by 6 percent, from KEUR 2,474 in the first quarter of 2003 to KEUR 2,628 this year. At the same time pre-tax net income also improved by KEUR 107, from a loss of KEUR 481 in the first quarter to only KEUR -374. Likewise the results after tax improved over the same period a year earlier from a loss of KEUR 587 to only KEUR -480. Sales in the Healthcare Software Division amounted in the first quarter of 2004 to KEUR 1,377 (Q1/2003: KEUR 1,139), which means that we have achieved 21 percent growth. Sales in the Healthcare Service Division declined slightly in the first quarter of 2004, by 6.3 percent, from KEUR 1,335 to KEUR 1,251, a trend that was in line with expectations and resulted from the restructuring of this field of business. Both the cash flow and the EBITDA have improved. Whereas the cash flow from operating activity in Q1/2003 was KEUR 589, it now proved possible to generate KEUR 744. The EBITDA improved substantially from KEUR -20 (Q1/2003) to KEUR 193 in the comparable period in 2004. The trend was also positive in the rate at which new orders came in during the first quarter, particularly from outside Germany. The foreign share of sales in the first quarter of 2004 rose from 16.5 to 22.9 percent. The new orders will have their impact on sales revenue in the subsequent quarters. Nexus AG possesses a healthy balance sheet. The equity capital rate is still high and amounts to 89.9 percent. For further information:Ms Angelika Lange-Nexus AG 78052 D-Villingen- Schwenningen Tel.: +49 (0) 77 21/84 82 320 Fax: +49 (0) 77 21/84 82 888 angelika.lange@nexus-ag.de http://www.nexus-ag.de/ end of ad-hoc-announcement (c)DGAP 27.05.2004 ——————————————————————————– WKN: 522090; ISIN: DE0005220909; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, München, Hannover und Stuttgart 270820 Mai 04